These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7190078)
21. Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals. Litterst CL; Schweitzer VG Cancer Chemother Pharmacol; 1984; 12(1):46-9. PubMed ID: 6537802 [TBL] [Abstract][Full Text] [Related]
22. The metabolism of cis-dichlorodiammineplatinum (II): distribution, clearance, and toxicity. Lagasse LD; Pretorius RG; Petrilli ES; Ford LC; Hoeschele J; Kean C Am J Obstet Gynecol; 1981 Apr; 139(7):791-8. PubMed ID: 7193975 [TBL] [Abstract][Full Text] [Related]
23. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
24. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs. Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140 [TBL] [Abstract][Full Text] [Related]
25. Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin. Safirstein R; Daye M; Guttenplan JB Cancer Lett; 1983 Apr; 18(3):329-38. PubMed ID: 6682696 [TBL] [Abstract][Full Text] [Related]
26. Effect of cis- and trans-dichlorodiammineplatinum(II) on human tumor cell proliferation in diffusion chambers in vivo. Ambrose KR; Lowrey JS Cancer Res; 1982 May; 42(5):1769-73. PubMed ID: 7039818 [TBL] [Abstract][Full Text] [Related]
27. The interaction of platinum-based drugs with native biologically relevant proteins. Brauckmann C; Wehe CA; Kieshauer M; Lanvers-Kaminsky C; Sperling M; Karst U Anal Bioanal Chem; 2013 Feb; 405(6):1855-64. PubMed ID: 23052861 [TBL] [Abstract][Full Text] [Related]
28. Interaction of platinum with metallothionein-like ligands in the rat kidney after administration of cis-dichlorodiammine platinum II. Mason R; Edwards IR; McLaren SJ Chem Biol Interact; 1984 Apr; 49(1-2):165-76. PubMed ID: 6539175 [TBL] [Abstract][Full Text] [Related]
29. Clearance, metabolic fate and tissue distribution of an injected bolus of photoaffinity-labeled rat androgen binding protein. Danzo BJ; Eller BC Biol Reprod; 1984 Sep; 31(2):259-70. PubMed ID: 6541061 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the complex between native and reduced bovine serum albumin with aquacobalamin and evidence of dual tetrapyrrole binding. Dereven'kov IA; Hannibal L; Makarov SV; Makarova AS; Molodtsov PA; Koifman OI J Biol Inorg Chem; 2018 Jul; 23(5):725-738. PubMed ID: 29721769 [TBL] [Abstract][Full Text] [Related]
31. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid. Daley-Yates PT; McBrien DC Biochem Pharmacol; 1982 Jul; 31(13):2243-6. PubMed ID: 6889863 [TBL] [Abstract][Full Text] [Related]
32. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. Pardridge WM; Mietus LJ J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850 [TBL] [Abstract][Full Text] [Related]
34. [Organ distribution of bovine serum albumin administered intragastrically in the rat]. Mazo VK; Zorin SN; Shirina LI Vopr Pitan; 1985; (3):49-52. PubMed ID: 3898579 [TBL] [Abstract][Full Text] [Related]
35. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Siddik ZH; Newell DR; Boxall FE; Harrap KR Biochem Pharmacol; 1987 Jun; 36(12):1925-32. PubMed ID: 3297068 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of protein binding effect on local disposition of oxacillin in rat liver by a two-compartment dispersion model. Yano Y; Yamaoka K; Minamide T; Nakagawa T; Tanaka H J Pharm Pharmacol; 1990 Sep; 42(9):632-6. PubMed ID: 1981901 [TBL] [Abstract][Full Text] [Related]
37. Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin. Ottnad E; Via DP; Sinn H; Friedrich E; Ziegler R; Dresel HA Biochem J; 1990 Feb; 265(3):689-98. PubMed ID: 2154967 [TBL] [Abstract][Full Text] [Related]
38. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133 [TBL] [Abstract][Full Text] [Related]
39. Sensitive determination of plasma protein binding of cationic drugs using mixed-mode solid-phase microextraction. Peltenburg H; Bosman IJ; Hermens JL J Pharm Biomed Anal; 2015 Nov; 115():534-42. PubMed ID: 26313333 [TBL] [Abstract][Full Text] [Related]
40. Plasma clearance of sulfobromophthalein and its interaction with hepatic binding proteins in normal and analbuminemic rats: is plasma albumin essential for vectorial transport of organic anions in the liver? Inoue M; Okajima K; Nagase S; Morino Y Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7654-8. PubMed ID: 6584879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]